We demonstrate that miR-125a-dependent inhibition of HAX-1 re-sensitizes laryngeal cancer stem cells to cisplatin through mitochondrial apoptosis pathway (Figure 9). The gene discussed is HAX1; the disease is laryngeal carcinoma.